Αρχική World News Announcing ‘Cancer Revolution’ – a world-first exhibition to engage people with progress...

Announcing ‘Cancer Revolution’ – a world-first exhibition to engage people with progress against cancer

Visualisation of the Cancer Revolution exhibit

A sneak peak of the Cancer Revolution exhibition.

“Look, we can make bacteria interesting – just imagine what we can do with cancer biology!”

Those were the words of Sir Ian Blatchford, director of the Science Museum Group back in 2017 when we first spoke about the idea of creating a cutting-edge, world-first exhibition about cancer.

Our research engagement team were looking for ways to talk about cancer science in stimulating and engaging ways, but knew that the science can sometimes come over as a bit impenetrable. In discussion with Ian and his team at the Science Museum, we got excited by the idea of an experience that would showcase the incredible scientific and medical progress we’ve seen in recent decades and our optimism for the future, while also bringing out the enormous impact cancer has on those it affects, and the importance of continuing to make progress against the disease.

Underpinning the idea was a belief shared by both organisations, that a public that is engaged with scientific progress is a public that is more supportive of science itself – something we have seen to be of huge importance lately

National museums’ thorough approach means developing an exhibition takes a while – and the pandemic hasn’t helped – but today I’m delighted to share the news that ‘Cancer Revolution: Science, innovation and hope’ will open its doors in October 2021 at Manchester’s Science and Industry Museum, before relocating to the Science Museum in London in May 2022.

As the exhibition’s Expert Partner, we’ve been working closely with the Science Museum Group’s curators to help shape the exhibition, giving them access to our researchers and clinical experts, and the insights of our Involvement Network of people affected by cancer.

I’m incredibly excited to see the resulting exhibition, which will present the stories and experiences of those affected by cancer alongside the people who study and treat it, while taking visitors on a journey into some of the latest most cutting-edge research going on around the world.

It will also put current cancer care into historical context, featuring a range of objects, new artist commissions and installations, film, and photography.

Visualisation of the science museum exhibit.

The exhibit will feature stories from those affected by cancer alongside the latest most cutting-edge research going on around the world.

Cancer Revolution comes at an important time for those who work to keep cancer on the public agenda. Quite understandably, as well as having a huge impact on health services around the world, and hindering scientific progress, the COVID-19 pandemic has dominated headlines and public imagination. Yet cancer hasn’t gone away and if anything, our work to beat it has become all the more urgent. Getting the spotlight back on cancer is a top priority for our community.

If there’s any silver lining to be found from the last year it’s that, more than ever, the public truly recognise the power of science to shape society for the better. The development of vaccines against the coronavirus is a chapter in history of which the research community can be immensely proud.

So I hope that, with an exhibition like Cancer Revolution, we can connect people with an equally important, if unfinished, chapter in the story of humanity: our mission to overcome a disease that affects so many of us, and still claims too many lives too early.

Iain Foulkes is Cancer Research UK’s executive director of research and innovation

More on this topic

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Combining existing drugs improves prostate cancer survival

Adding abiraterone to standard hormone therapy improves survival for men with high-risk prostate cancer that’s not spread elsewhere in the body. “Today’s results are the...

New Combination of Old Drugs Improves Survival in Patients with Prostate Cancer [ESMO Congress 2021 Press Release]

LBA4_PR - Abiraterone acetate plus prednisolone (AAP) with or without enzalutamide (ENZ) added to androgen deprivation therapy (ADT) compared to ADT alone for men...

Immunotherapy Prolongs Survival in Recurrent, Persistent or Metastatic Cervical Cancer [ESMO Congress 2021 Press Release]

LBA2_PR - Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for persistent, recurrent, or metastatic cervical cancer: Randomized, double-blind, phase 3 KEYNOTE-826 study N. Colombo1, C....

Woman Diagnosed with Breast Cancer at 33 Launches Self-Examination App

Jessica Baladad has had a long history with self-examinations after a breast cancer scare in her early 20s. This habit helped save her life,...

Extended Adjuvant Treatment with Letrozole Results in Longer Survival in Postmenopausal Patients with Breast Cancer

According to results from a prospective, open-label, phase III study conducted in 69 Italian hospitals within the Gruppo Italiano Mammella among the postmenopausal patients...

Foodie Fridays: Apple Bok Choy Salad

While the temps may still be in the 80’s, apple season is upon us! Give this Apple Bok Choy salad a try!  It is...